There are no medications that are specifically marketed for the treatment of autism. There
does exist, however, an extensive body of literature describing both open-label and …

The use of pharmacologic agents as a component of treatment for children and adults with
autism spectrum disorders is common and a substantial body of literature describing …

Although there is a proliferating literature on the pharmacotherapy of autism, the results of
these studies are often conflicting. A definitive medical intervention for the core symptoms of …

Although no pharmacological or behavioral therapy has currently proven effective for
treating all core symptoms of autism, many dysfunctional behaviors may be treated …

Autism is a neurodevelopmental disorder, with a multifactorial etiology, characterized by
severe abnormalities in communications, social awareness and skills, and the presence of …

Autism spectrum disorders are characterized by impairment in social reciprocity,
disturbances in language and communication, restricted interests and repetitive behaviors of …

Autistic disorder is characterized by qualitative impairment in the areas of social interaction
and communication, as well as stereotypic, repetitive patterns of behavior. In addition to the …

Autism is a neurobiological disorder. The core clinical features of autism include impairment
in social interaction, impairments in verbal and nonverbal communication, and restricted …

Pharmacological Therapies for Autism Spectrum Disorder: A Review - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Children with autism spectrum disorder present with a high rate of maladaptive behaviors
and comorbid psychopathology. Psychopharmacologic treatment is frequently used in this …